Abstract:We paid attentions on recently published paper by Lei and colleagues [ [1] Lei Y. Yang G. Hu L. et al. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. Int. J. Cardiol. 2017 Sep 15; 243: 413-420 Abstract Full Text Full Text PDF PubMed Scopus (53) Google Scholar ]. The authors highlighted that DDP-4 inhibition with anagliptin contributed to atherosclerotic resistance. Intriguingly, the protective roles of DPP-4 inhibition during high glucose(HG)-/oscillating glucose(OG)-caused metabolic memory (MM) expanded their therapeutic effects [ 2 Sala L.L. Genovese S. Ceriello A. Effect of vildagliptin, compared to sitagliptin, on the onset of hyperglycemia-induced metabolic memory in human umbilical vein endothelial cells. Cardiovasc. Pharm. Open Access. 2017; 6: 203https://doi.org/10.4172/2329-6607.1000203 Crossref Google Scholar , 3 Pujadas G. De Nigris V. Prattichizzo F. et al. The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory. Endocrine. 2016; 56: 509-520 Crossref PubMed Scopus (43) Google Scholar ]. It has been commonly indicated that early HG or OG was remembered despite tight glucose control on micro-/macro-vasculature that referred to MM [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], and the mechanisms complied with persistent epigenetic modification [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ]. Although our prior studies suggested that targeting histone demethylase KDM3A might limit MM-induced constant vascular remodeling [ [5] Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], there existed great differences to transfer above achievements onto clinical trials. Response to letter “DPP-4 inhibition as a therapeutic strategy to ameliorate diabetic metabolic memory”International Journal of CardiologyVol. 256PreviewRecently, we have published our work entitled “Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in apolipoprotein E-deficient mice under chronic stress” [1]. In our study, anagliptin ameliorated harmful changes in plasma dipeptidyl peptidase-4 (DPP4), glucagon-like protein-1 (GLP-1), and adiponectin and decreased the parameters of inflammatory response and oxidative stress and proteolysis in the plaques of the stressed mice, suggesting that the ability of DPP4 inhibition to lessen over-activated inflammation, oxidative stress production and proteolysis may have a salutary effect on vascular damage under stress conditions through GLP-1-mediated adiponectin production in apolipoprotein E-deficient (ApoE−/−) mice fed high fat-diet. Full-Text PDF

Dose rectification of an imbalance between DPP4 and GLP‐1 ameliorates chronic stress‐related vascular aging and atherosclerosis?

Dose rectification of an unbalance between DPP4 and GLP-1 ameliorates chronic stress-related vascular aging and atherosclerosis?

DPP-4/GLP-1 Axis as a Potential Therapeutic Target in Chronic Stress-related Vascular Aging and Atherosclerosis

Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress

Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: the Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.

Increased Dipeptidyl Peptidase-4 Accelerates Diet-Related Vascular Aging and Atherosclerosis in ApoE-deficient Mice under Chronic Stress.

Increased Dipeptidyl Peptidase-4 Accelerates Chronic Stress-Related Thrombosis in a Mouse Carotid Artery Model.

Dipeptidyl Peptidase-4 Inhibition Prevents Lung Injury in Mice under Chronic Stress Via the Modulation of Oxidative Stress and Inflammation

DPP-4 Inhibition As a Therapeutic Strategy to Ameliorate Diabetic Metabolic Memory.

Statins Mitigate Stress-Related Vascular Aging and Atherosclerosis in apoE-Deficient Mice Fed High Fat-Diet: The Role of Glucagon-Like Peptide-1/Adiponectin Axis

GW29-e1504 Chronic restraint stress impairs ischemia-induced neovascularization through DPP-4-dependent pathway

DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging

Targeting endothelial dysfunction and inflammation

The Regulatory Role of DPP4 in Atherosclerotic Disease

Potential Role of Dipeptidyl Peptidase-4 in Regulating Mitochondria and Oxidative Stress in Cardiomyocytes

The protective role of DPP4 inhibitors in atherosclerosis

A Role for DPP4 Expression via Oxidized LDL/TLR4/TRIF/CD36 Pathways in Human Obesity and Atherosclerosis

PL-010 Chronic Mild Stress Improves Glucose Homeostasis Via Myonectin-Mediated Suppression of Sympathetic Activity in High-Fat Diet-Fed Mice

A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction

Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress